New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor

Author： Wilcox R.A. Primrose W.U. Nahorski S.R. Challiss R.A.J.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.11, 1998-11, pp. : 467-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mycotoxin paxilline inhibits the cerebellar inositol 1,4,5-trisphosphate receptor

By Longland C.L. Dyer J.L. Michelangeli F.

European Journal of Pharmacology, Vol. 408, Iss. 3, 2000-11 ,pp. : 219-225

Elsevier

Access to resources Recommend Favorite

Highly selective receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes

By Novakova M. Ela C. Bowen W.D. Hasin Y. Eilam Y.

European Journal of Pharmacology, Vol. 353, Iss. 2, 1998-07 ,pp. : 315-327

Elsevier

Access to resources Recommend Favorite

Chronic U50,488H abolishes inositol 1,4,5-trisphosphate and intracellular Ca 2+ elevations evoked by -opioid receptor in rat myocytes

By Jian-Zhong S. Tak-Ming W.

European Journal of Pharmacology, Vol. 307, Iss. 3, 1996-07 ,pp. : 323-329

Elsevier

Access to resources Recommend Favorite

D-Myo Inositol 1,2,6, Trisphosphate ( -Trinositol, pp56) - an overview

By Bell D. McDermott B.J.

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 689-696

Elsevier

Access to resources Recommend Favorite

ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets

By Vanags D.M. Lloyd J.V. Rodgers S.E. Bochner F.

European Journal of Pharmacology, Vol. 358, Iss. 1, 1998-09 ,pp. : 93-100

Elsevier

Access to resources Recommend Favorite